TR2021015778A2 - MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD - Google Patents
MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHODInfo
- Publication number
- TR2021015778A2 TR2021015778A2 TR2021/015778A TR2021015778A TR2021015778A2 TR 2021015778 A2 TR2021015778 A2 TR 2021015778A2 TR 2021/015778 A TR2021/015778 A TR 2021/015778A TR 2021015778 A TR2021015778 A TR 2021015778A TR 2021015778 A2 TR2021015778 A2 TR 2021015778A2
- Authority
- TR
- Turkey
- Prior art keywords
- contact lens
- peg
- cleaning solution
- mixing
- production method
- Prior art date
Links
- 238000004140 cleaning Methods 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920002413 Polyhexanide Polymers 0.000 claims abstract description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 14
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 229920001992 poloxamer 407 Polymers 0.000 claims abstract description 7
- 229940044476 poloxamer 407 Drugs 0.000 claims abstract description 7
- 239000011780 sodium chloride Substances 0.000 claims abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims abstract description 5
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 5
- 239000000080 wetting agent Substances 0.000 claims abstract description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract 3
- 229940124274 edetate disodium Drugs 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims description 16
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000000284 resting effect Effects 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 239000000872 buffer Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004327 boric acid Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 229910004844 Na2B4O7.10H2O Inorganic materials 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 17
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 102100022339 Integrin alpha-L Human genes 0.000 description 8
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229920001983 poloxamer Polymers 0.000 description 7
- 239000000882 contact lens solution Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- -1 etc.) Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 229960000502 poloxamer Drugs 0.000 description 5
- 229940093158 polyhexanide Drugs 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229940123208 Biguanide Drugs 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- OEZPKXDBWNXBRE-UHFFFAOYSA-N 2,3-bis(2-hydroxyethoxy)propyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(OCCO)COCCO OEZPKXDBWNXBRE-UHFFFAOYSA-N 0.000 description 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940074046 glyceryl laurate Drugs 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 229920001987 poloxamine Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- AOWCOHYBGYRYGE-UHFFFAOYSA-N 1-[2,3-bis(2-oxopropoxy)propoxy]propan-2-one Chemical compound CC(=O)COCC(OCC(C)=O)COCC(C)=O AOWCOHYBGYRYGE-UHFFFAOYSA-N 0.000 description 1
- QIZPVNNYFKFJAD-UHFFFAOYSA-N 1-chloro-2-prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1Cl QIZPVNNYFKFJAD-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 229920000469 amphiphilic block copolymer Polymers 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960003872 benzethonium Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000003916 ethylene diamine group Chemical group 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 238000011086 high cleaning Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 229940077412 peg-12 laurate Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229940033331 soy sterol Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229940032085 sucrose monolaurate Drugs 0.000 description 1
- 229940035023 sucrose monostearate Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 108010019783 tear proteins Proteins 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229920001664 tyloxapol Polymers 0.000 description 1
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
- 229960004224 tyloxapol Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
Bu buluş, özellikle tıp, kozmetik vb alanlarda, kontakt lens temizleme solüsyonu üretim sektöründe kullanılan kullanılabilen multifonksiyonlu ekonomik kontakt lens temizleme solüsyonu ve üretim yöntemi ile ilgili olup, özelliği; kontakt lensin göze takılma ve çıkarılmasında kolaylık sağlayan viskozite ayarlayıcı ve ıslatıcı olarak % 0.025 polyvinilprolidon (PVD), yüzey gerilimini ayarlamak/temizleme kapasitesini arttırmak için Poloksamer 407, protein giderici ve göz sıvı pH? nı sağlamak için borat tamponu (borik asid; % 1,25)-Na2B4O7.10H2O; % 0.18), osmolarite ayarı için sodyum 15 klorür (NaCl), edetat disodyum (Na2EDTA) ve polihekzametilen biguanid (PHMB) içermesidir.This invention relates to the multifunctional economic contact lens cleaning solution and production method that can be used in the contact lens cleaning solution production sector, especially in the fields of medicine, cosmetics etc. 0.025% polyvinylprolidone (PVD) as a viscosity adjuster and wetting agent that facilitates the wearing and removal of the contact lens, Poloxamer 407 to adjust the surface tension/increase the cleaning capacity, protein remover and eye liquid pH? borate buffer (boric acid; 1.25%)-Na2B4O7.10H2O; 0.18%), sodium 15 chloride (NaCl), edetate disodium (Na2EDTA) and polyhexamethylene biguanide (PHMB) for osmolarity adjustment.
Description
TARIFNAME MULTIFONKSIYONLU EKONOMIK KONTAKT LENS TEMIZLEME SOLÜSYONU VE ÜRETIM YÖNTEMI Teknolojik Alan: Bu bulus, özellikle tip, kozmetik vb alanlarda, kontakt lens temizleme solüsyonu üretim sektöründe kullanilan kullanilabilen multifonksiyonlu ekonomik kontakt lens temizleme solüsyonu ve üretim yöntemiile ilgilidir. DESCRIPTION MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD Technological Field: This invention is particularly useful in the fields of medicine, cosmetics, etc., in contact lens cleaning solution production. Multifunctional economic contact lens cleaning used in the industry solution and production method.
Teknigin Bilinen Durumu: Çok amaçli kontakt lens solüsyonlari (GMDN: 48074 ve Sinif llb) orta derecede riskli tibbi cihaz sinifindadir. Kontakt Lens Temizleme Solüsyonu (KLTS-mps) bir kontakt lensin (tipi ne olursa olsun) mutlaka kullanimdan sonra temizlenip dezenfekte edilmesi, durulanmasi ve kullanim öncesinde isitilmasi gereklidir. Materyal bilesimine göre iki tip kontakt lens çesidi (sert gaz geçirgen ve yumusak hidrojel) bulundugundan, kullanilan temizleme (dezenfeksiyon) yönetminin de lens materyaline de uygun olmasi gerekmektedir. Çok amaçli temizleme (dezenfeksiyon) solüsyonlari, tek bir solüsyonun temizleme, dezenfeksiyon, yikama ve kontakt lensleringüvenle bekletilmesi amaciyla kullanilan solüsyonlardir. Bu solüsyonlarin avantajlari arasinda göz için düsük toksik teki göstermeleri ve kontakt lens tarafindan düsük emilimi sayesinde kontakt lenslerin ömrünü uzatmalari sayilabilir. Ayni zamanda çok amaçli temizleme (dezenfeksiyon) solüsyonlari bozulmadiklari için dezenfeksiyon aktiviteleri devamlilik saglar. Bu solüsyonlar, kullanimlarinin kolay olmasi sayesinde kontakt lens kullanicilari için bir avantaj olarak görülmektedir. Kontakt lens bakiminda birden fala ürünün bir arada kullanilmasindaki zorluk ve daha basit sistemler gelistirilmesine yönelik talepler dogrultusunda, kontakt lens bakim sistemlerindeki basamaklarin bir araya getirildigi tüm lenslere uygun, yeni, tamamen yerli ve ISO 14729 standartlarina uygun çok amaçli temizleme (dezenfeksiyon) solüsyonlarinin gelistirilmesi ve üretime sunulmasi projemizin baslica amacidir. Pazar incelemesi yapildiginda kontakt lens temizleme ve bakim solüsyonu pazarina ABD, Çin, Hindistan ve Avrupa “nin hakim oldugu görülmektedir. Dolayisiyla kontakt lens temizleme ve bakim solüsyonu ithalatina ülkemiz yillik milyonlarca dolar harcamaktadir. Kontakt lens temizleme ve bakim solüsyonunda disa bagimliligimizi azaltmak ve hatta ihracatini yapmak ülkemiz için büyük fayda saglayacaktir. State of the Art: Multi-purpose contact lens solutions (GMDN: 48074 and Class IIb) moderate risk It is in the medical device class. Contact Lens Cleaning Solution (KLTS-mps) is a contact lens the lens (regardless of the type) must be cleaned and disinfected after use, It must be rinsed and heated before use. Two types according to material composition Since there are contact lens types (hard gas permeable and soft hydrogel), the used that the cleaning (disinfection) method is suitable for the lens material required. Multi-purpose cleaning (disinfection) solutions, a single solution for cleaning, disinfection, washing and keeping contact lenses safely the solutions used. The advantages of these solutions include low toxicity to the eye. contact lenses, thanks to their single display and low absorption by the contact lens. can extend their lifespan. At the same time, multi-purpose cleaning (disinfection) Disinfection activities provide continuity as the solutions do not deteriorate. This The solutions are an easy-to-use solution for contact lens wearers. seen as an advantage. More than one product together in contact lens care difficulties in using it and demands for simpler systems development In line with this, the steps in contact lens care systems are brought together. new, completely native, suitable for all lenses and multi-purpose in accordance with ISO 14729 standards development and production of cleaning (disinfection) solutions is the main purpose of our project. When market review is done, contact lens cleaning and The care solution market is dominated by the USA, China, India and Europe. is seen. Therefore, the import of contact lens cleaning and care solution Our country spends millions of dollars annually. Contact lens cleaning and care It is important for our country to reduce our dependence on foreign products and even to export them. will be of great benefit.
Bilindigi gibi kornea gündüz saatlerinde direkt havadan, gece uygu sirasinda göz kapaklari kapali oldugundan kapaklarin arka yüzeyindeki kilcal damarlardan oksijen almaktadir. Lens gözde iken gözyasi tabakasiyla yikanir. Bu tabakanin içerdigi lipid, protein, mukus gibi kalintilar, çevresel kontaminasyon yapicilar ve kozmetik artiklar lens yüzeyini kaplayabilir. Lens yüzeyine yapisan çevresel kontaminasyon yapicilar gözyasi nitelik ve miktarindan ayrica lens materyalinin özelliginden etkilenir. Özellikle wmusak lensler hidrofilik olduklarindan lens yüzeyine baglanma veya lens matrisine geçme egilimdeki kontaminasyon yapicilari fazla çekerler. Tüm bu sebeplerden ötürü lens bakiminda temizleme çözeltileri önem tasimaktadir. Bu çözeltilerde dikkat edilmesi gereken nokta steril, izotonik, dogru pH ve vizkozitede, lens ile geçimli ve uygun bakterisit içerecek sekilde üretilmis olmalari gerekmektedir. basvuru dosyasinda LFA-l aracili hastaliklarin tedavisi için bilesikler ve yöntemler anlatilmaktadir. Özellikle, LFA-l antagonistleri burada tarif edilmektedir ve bu antagonistler, LFA-l aracili hastaliklarin tedavisinde kullanilmaktadir. Bulusun bir yönü, hastaya LFA-l aracili bir hastalik teshisi konduktan sonra, LFA-l aracili bir hastaligin teshisini ve bir LFA-l antagonistinin uygulanmasini saglar. Bazi düzeneklerde LFA-l aracili tedavi edilen hastaliklar, kuru göz bozukluklaridir. Ayrica burada, LFA-l antagonistleri olan bilesiklerin tanimlanmasina yönelik yöntemler saglanmaktadir. Bulusta kullanilan katki maddeleri arasinda izotonize edici maddeler (öm., Sodyum klorür, vb.), Tampon maddesi (öm., Borik asit, sodyum monohidrojen fosfat, sodyum dihidrojen fosfat, vb.), Koruyucular (örn., Benzalkonyum klorür, benzetonyum klorür, klorobütanol, vb.) koyulastiricilar (örnegin, laktoz, mannitol, maltoz, vb. gibi sakarit; örnegin, hiyaluronik asit veya bunun tuzu, örnegin sodyum hiyalüronat, potasyum hiyalüronat, vb; ör., kondroitin sülfat vb. gibi mukopolisakarit; ör. sodyum poliakrilat, karboksivinil polimer, çapraz bagli poliakrilat, polivinil alkol, polivinil pirolidon, metil selüloz, hidroksi propil metilselüloz, hidroksietil selüloz, karboksimetil selüloz, hidroksi propil selüloz veya teknikte uzman kisilerce bilinen diger ajanlar) kullanilmistir. Diger hidrofilik iyonik olmayan yüzey aktif maddeler arasinda sinirlama olmaksizin PEG-10 laurat, PEG-12 laurat, PEG-20 laurat, PEG-32 distearat, PEG-40 stearat, PEG-100 stearat, PEG-20 dilaurat, PEG-25 gliseril trioleat, PEG-32 dioleat, PEG-20 gliseril laurat, PEG-30 gliseril laurat, PEG-20 gliseril stearat, PEG-20 gliseril oleat, PEG-30 gliseril oleat, PEG-30 gliseril laurat, PEG-40 gliseril laurat, PEG-40 hurma çekirdegi yagi, PEG-50 hidrojene hint yagi, PEG-40 hint yagi, PEG-35 hint yagi, PEG-60 hint yagi, PEG-40 hidrojene hint yagi, PEG-60 hidrojene hint yagi, PEG-60 misir yag, PEG-6 kaprat / kaprilat gliseridler, PEG-8 kaprat / kaprilat gliseritler, poligliseril-lO laurat, PEG-30 kolesterol, PEG-25 fito sterol, PEG-30 soya sterol, PEG-20 trioleat, PEG-40 sorbitan oleat , PEG-80 sorbitan laurat, polisorbat 20 , polisorbat 80, POE-9 lauril eter, POE-23 lauril eter, POE-lO oleil eter, POE-20 oleil eter, POE-20 stearil eter, tokoferil PEG-100 süksinat, PEG-24 kolesterol, poligliseril- 1001eat, Tween 40, Tween 60, sükroz monostearat, sükroz monolaurat, sükroz poloksamerler. As it is known, the cornea is directly exposed to the air during the daytime and to the eye during the night. Since the caps are closed, oxygen from the capillaries on the back surface of the caps takes. While the lens is in the eye, it is washed with a layer of tears. The lipid contained in this layer, residues such as protein, mucus, environmental contaminants and cosmetic residues may cover the lens surface. Environmental contaminants adhering to the lens surface It is affected by the quality and amount of tears, as well as the properties of the lens material. Especially Since wmusk lenses are hydrophilic, they do not attach to the lens surface or attach to the lens matrix. They attract too much contaminants that tend to pass. For all these reasons Cleaning solutions are important in lens care. Caution in these solutions the required point is sterile, isotonic, at the correct pH and viscosity, compatible with the lens and suitable They must be produced to contain bactericide. Compounds and methods for the treatment of LFA-1-mediated diseases in the application file is explained. In particular, LFA-1 antagonists are described herein and antagonists are used in the treatment of LFA-1-mediated diseases. find one The aspect is that after the patient has been diagnosed with an LFA-1-mediated disease, an LFA-1-mediated disease provides diagnosis of the disease and administration of an LFA-1 antagonist. Some diseases treated by LFA-1 in embodiments are dry eye disorders. Moreover Here, methods for identifying compounds that are LFA-1 antagonists is provided. Among the additives used in the invention, isotonizing agents (e.g., sodium chloride, etc.), buffering agent (e.g., boric acid, sodium monohydrogen phosphate, sodium dihydrogen phosphate, etc.), preservatives (eg, Benzalkonium chloride, benzetonium chloride, chlorobutanol, etc.) thickeners (eg, lactose, mannitol, maltose, etc. saccharide such as; for example, hyaluronic acid or its salt, eg sodium hyaluronate, potassium hyaluronate, etc.; eg, chondroitin sulfate etc. mucopolysaccharide such as; e.g. sodium polyacrylate, carboxyvinyl polymer, cross-linked polyacrylate, polyvinyl alcohol, polyvinyl pyrrolidone, methyl cellulose, hydroxy propyl methylcellulose, hydroxyethyl cellulose, carboxymethyl cellulose, hydroxy propyl cellulose or known to those skilled in the art other agents) were used. Other hydrophilic nonionic surfactants without limitation PEG-10 laurate, PEG-12 laurate, PEG-20 laurate, PEG-32 distearate, PEG-40 stearate, PEG-100 stearate, PEG-20 dilaurate, PEG-25 glyceryl trioleate, PEG-32 dioleate, PEG-20 glyceryl laurate, PEG-30 glyceryl laurate, PEG-20 glyceryl stearate, PEG-20 glyceryl oleate, PEG-30 glyceryl oleate, PEG-30 glyceryl laurate, PEG-40 glyceryl laurate, PEG-40 palm kernel oil, PEG-50 hydrogenated castor oil, PEG-40 castor oil, PEG-35 castor oil, PEG-60 castor oil, PEG-40 hydrogenated castor oil, PEG-60 hydrogenated castor oil, PEG-60 corn oil, PEG-6 caprate / caprylate glycerides, PEG-8 caprate / caprylate glycerides, polyglyceryl-10 laurate, PEG-30 cholesterol, PEG-25 phytosterol, PEG-30 soy sterol, PEG-20 trioleate, PEG-40 sorbitan oleate , PEG-80 sorbitan laurate, polysorbate 20 , polysorbate 80, POE-9 lauryl ether, POE-23 lauryl ether, POE-10 oleyl ether, POE-20 oleyl ether, POE-20 stearyl ether, tocopheryl PEG-100 succinate, PEG-24 cholesterol, polyglyceryl- 1001eat, Tween 40, Tween 60, sucrose monostearate, sucrose monolaurate, sucrose poloxamers.
CA2501396A1 yayin numarali “Lens Bakim Bilesimi ve Yöntemi” baslikli patent basvuru dosyasinda çok daha düsük konsantrasyonda dezenfekte edici ajanlara sahip ve göz için daha az tahris edici olan tamponlu sulu kontakt lens dezenfekte edici solüsyon açiklanmaktadir. Çözeltilerin tonisitesi 200 ila 450 mOsm / kg, pH degeri 6 ile 8 arasindadir ve klorür iyonu konsantrasyonu 1500 ppm'nin altindadir. 1 ppm'den az antimikrobiyal içerrnesine ragmen, solüsyonlar 15 dakika temas içinde C. albicans'a karsi etkilidir. Mevcut bilesimler tercihen etkili miktarda bir kenetleme bileseni içerir. Patent titled “Lens Care Composition and Method” with publication number CA2501396A1 have a much lower concentration of disinfecting agents in the application file, and buffered aqueous contact lens disinfecting solution that is less irritating to the eye is explained. The tonicity of the solutions is 200 to 450 mOsm / kg, the pH value is 6 to 8 and the chloride ion concentration is below 1500 ppm. less than 1 ppm Despite containing antimicrobial, solutions are susceptible to C. albicans within 15 minutes of contact. counter effective. The present compositions preferably contain an effective amount of a chelating component.
Etilendiamintetraasetik asit (EDTA), bunlarin tuzlari ve karisimlari özellikle etkili olmasina ragmen, herhangi bir uygun, tercihen oftalmik açidan kabul edilebilir selatlayici bilesen mevcut bilesimlere dahil edilebilir. Uygun viskozite indükleyici bilesenler arasinda, bunlarla sinirli olmamak üzere, polivinilpirolidon, suda çözünür dogal zamklar, selülozdan türetilmis polimerler ve benzeri yer alir. Tyloxapol,% 0.005 degisen konsantrasyonlarda uygun sekilde kullanilir. Çözelti tiroksapol içeriyorsa, ila% 0.2 konsantrasyonda bir poloksamer veya bir poloksamer karisimi içerir. ayrica mevcut bulus biguanid ve borat tamponu içermektedir. Mevcut bilesimler tercihen etkili miktarda bir kenetleme bileseni içerir. Etilendiamintetraasetik asit (EDTA), bunlarin tuzlari ve karisimlari özellikle etkili olmasina ragmen, herhangi bir uygun, tercihen oftalmik açidan kabul edilebilir selatlayici bilesen mevcut bilesimlere dahil edilebilir. Ethylenediaminetetraacetic acid (EDTA), salts and mixtures thereof are particularly effective. However, any suitable, preferably ophthalmically acceptable The chelating component can be included in existing compositions. Suitable viscosity inducer components include, but are not limited to, polyvinylpyrrolidone, water-soluble natural gums, polymers derived from cellulose, and the like. Tyloxapol, 0.005% used appropriately in varying concentrations. If the solution contains thyroxapol, It contains a poloxamer or a mixture of poloxamers at a concentration of from 0.2% to 0.2%. Moreover The present invention includes biguanide and borate buffer. Existing compositions are preferably effective quantity of a clamping component. Ethylenediaminetetraacetic acid (EDTA) Although salts and mixtures thereof are particularly effective, any suitable, preferably The ophthalmically acceptable chelating component may be included in existing compositions.
Tercih edilen polimerik antimikrobiyal ajanlar sunlari içerir: polimerik bir kuaterner amonyum bilesigi olan polikuaterniyum-l ve polimerik bir biguanid olan poliheksametilen biguanid ("PHMB"). Preferred polymeric antimicrobial agents include: a polymeric quaternary polyquaternium-1, which is an ammonium compound, and a polymeric biguanide. polyhexamethylene biguanide ("PHMB").
Yukarida yer alan basvurular lens solüsyon formülasyonlari için yenilikçi bir basamak saglayabilmis olsa da göz konforunu arttirma, TSE-ISO 14729 standardina uygunluk, temizleme ve dezenfeksiyon özelliklerinin yüksekligi, tüm kontakt lens tiplerine uygunluk ve ekonomik avantajli olma özelliklerinin hepsini bir arada saglayan bir kontak lens solüsyonu üretimi suana kadar mümkün olmamistir. The above references are an innovative stepping stone for lens solution formulations. increasing eye comfort, compliance with TSE-ISO 14729 standard, high cleaning and disinfection properties, suitable for all contact lens types a system that provides all the features of convenience and economic advantage. Contact lens solution production has not been possible until now.
Bulusun Tanimi: Bu bulus, yukarida bahsedilen dezavantajlarin üstesinden gelebilen multifonksiyonlu ekonomik kontakt lens temizleme solüsyonu ve üretim yöntemiolup, özelligi; göz konforunu arttiran, TSE-ISO 14729 standardina uygun, temizleme ve dezenfeksiyon özellikleri yüksek, tüm kontakt lens tiplerine uygun ve ekonomik olarak avantajli olma özelliklerinin hepsini bir arada saglayan bir kontak lens solüsyonudur. Description of the Invention: This invention is a multifunctional device that can overcome the above mentioned disadvantages. It is an economical contact lens cleaning solution and production method. eyelash Cleaning and disinfection in accordance with the TSE-ISO 14729 standard, increasing the comfort high features, suitable for all contact lens types and being economically advantageous It is a contact lens solution that provides all of its properties together.
F orrnülasyonla birlikte gelistirilecek üretim teknolojisi özellikle steril ortamda üretim zorunlulugu olan ürünler için yeni bir alternatif olacaktir ve farkli ürünlerin eldesine kapi aralayacaktir. Ülkemizde özellikle sanayisi az gelismis bölgelerinden olan Güneydogu Anadolu Bölgesi basta olmak üzere diger bölgelerde faaliyet gösteren firmalar arasinda aseptik kosullarda ürün elde etme, Ar-Ge ve inovasyon bilinci aratacaktir. Öncelikle KLTS üretimindeki formülasyonlar genel olarak; ilk hasamakda solüsyonlarin suyun kaynama sicakligina kadar yükseltilmesi ve tekrar oda sicakligina kadar sogutulmasi gibi islemlerin gerekmesi maliyeti son derece artirmaktadir. Bu durum, hem zaman yönünden hem de elektrik ve isgücü maliyetinin ortaya çikaracagi ekstra maliyetleri yönünden üretici firmalara ek yük getirmektedir. Yine bu asamada selüloz türevlerinin çözünme güçlügü de ortaya çikan diger bir negatif unsur olarak karsimiza çikmaktadir. Bu nedenle, ayni piyasada mevcut ve en az onlar kadar etkili kontakt lens solüsyonlarinin üretimi son derece dikkat çekmektedir. Bu nedenle göz konforunu arttirici ve ekonomik yönden yeni formüllerin de gelistirilme zorunlulugu hedeflerimiz arasindadir. Ayrica, TSE-ISO 14729 standardina uygun, temizleme ve dezenfeksiyon özellikleri muadillerine göre yüksek, tüm kontakt lens tiplerine uygun, daha ekonomik lens solüsyonlari üretilmeye çalisilacak ve ilgili hedefler saglandiginda bulusun sagladigi avantajlar daha net bir sekilde ortaya çikacaktir. Production technology to be developed with formulation, especially production in sterile environment It will be a new alternative for products that are mandatory and it will be possible to obtain different products. the door will open. In our country, especially in the less developed regions of the industry, Operating in other regions, especially in the Southeast Anatolian Region, obtaining products in aseptic conditions between companies, R&D and innovation awareness will search. First of all, formulations in KLTS production are generally; in the first harvest raising the solutions to the boiling temperature of the water and returning them to room temperature The need for processes such as cooling the This This situation will result in both time and electricity and labor costs. It imposes an additional burden on manufacturers in terms of extra costs. Again at this stage The dissolution difficulty of cellulose derivatives is another negative factor. is coming our way. Therefore, they are available in the same market and at least as effective as they are. The production of contact lens solutions attracts a lot of attention. Therefore the eye The necessity of developing new formulas that increase comfort and economically are among our goals. In addition, cleaning and cleaning in accordance with the TSE-ISO 14729 standard. Its disinfection properties are higher than its counterparts, suitable for all contact lens types, more economical lens solutions will be tried to be produced and when the relevant targets are met The advantages provided by the invention will become clearer.
Sekillerin Açiklanmasi: Bulus, ilisikteki sekillere atifta hulunularak anlatilacaktir, böylece bulusun özellikleri daha açikça anlasilacak ve takdir edilecektir, fakat bunun amaci bulusu bu belli düzenlemeler ile sinirlamak degildir. Tam tersine, bulusun ilisikteki istemler tarafindan tanimlandigi alani içine dahil edilebilecek bütün alternatifleri, degisiklikleri ve denkliklerinin kapsanmasi amaçlaninistir. Gösterilen ayrintilar, sadece mevcut bulusun tercih edilen düzenlemelerinin anlatimi amaciyla gösterildigi ve hem yöntemlerin sekillendirilmesinin, hem de bulusun kurallari ve kavramsal özelliklerinin en kullanisli ve kolay anlasilir tanimini saglamak amaciyla sunulduklari anlasilmalidir. Bu çizimlerde; Sekil 1 Bulusun üretim basamaklarinin tablo halinde gösterimidir. Explanation of Figures: The invention will be described with reference to the accompanying figures so that the features of the invention will be more clearly understood and appreciated, but the purpose of this It's not about limiting yourself with regulations. On the contrary, the invention is satisfied by the appended claims. all alternatives, changes and It is intended to cover the equivalences. Details shown are present invention only shown for illustration of preferred embodiments and both methods formulation, as well as the rules and conceptual features of the invention. and it should be understood that they are presented to provide an easy-to-understand definition. This in drawings; Figure 1 is a tabular representation of the manufacturing steps of the invention.
Sekil 2 Bulusun üretim basamaklarinin tablo halinde gösterimidir. Figure 2 is a tabular representation of the manufacturing steps of the invention.
Bu bulusun anlasilmasina yardimci olacak sekiller ekli resimde belirtildigi gibi numaralandirilmis olup isimleri ile beraber asagida verilmistir. Figures to assist in understanding this invention are as indicated in the attached picture. are numbered and given below with their names.
Referanslarin Açiklanmasi: . PVD ilave edilmesi . 15 dk. karistirilmasi . Poloksamer 407 eklenmesi 40. borat tamponu eklenmesi 50. NaCl eklenmesi 60. 1200 rpm hizinda karistirilmasi 70. NazEDTA eklenmesi, 80. 30 dk. karistirilmasi 90. PHMB eklenmesi 100. 1 saat karistirilmasi 110. filtrelerden geçirilmesi 120. dinlendirilmesi Bulusun Açiklanmasi: Bulus; kontakt lensin göze takilma ve çikarilmasinda kolaylik saglayan Viskozite ayarlayici ve islatiei olarak % , yüzey gerilimini ayarlamak/temizleme kapasitesini arttirmak için Poloksamer 407, protein giderici ve polihekzametilen biguanid (PHMB) içermektedir. Explanation of References: . Addition of PVD . 15 min. mixing . Addition of Poloxamer 407 40. Addition of borate buffer 50. Addition of NaCl 60. Mixing at 1200 rpm 70. Addition of NazEDTA, 80. 30 min. mixing 90. Addition of PHMB 100. 1 hour stirring 110. passing through filters 120. Resting Description of the Invention: Meet; Viscosity that makes it easy to put on and remove the contact lens from the eye. % as setting and wetting agent, surface tension Poloxamer 407, protein remover and Contains polyhexamethylene biguanide (PHMB).
Bulusun üretim basamaklari; 50°C, 100 mL suya agirlikça %0.025 polyvinil prolidon (PVD) ilave edilmesi (10), sicakligin 25 0C 'ye düsürülerek 15 dk. karistirilmasi (20), disodyum (NazEDTA) eklenmesi (70), 25 0C ,de en az 30 dk. karistirilmasi (80), agirlikça % , 25 0C ”de en az 1 saat karistirilmasi (100), aseptik kosullarda filtrelerden geçirilmesi (110) ve 2 saat dinlendirilmesi (120) seklindedir. ( Sekil 1 ve Sekil 2) Bulusun Detayli Açiklanmasi: Sert ve gaz geçirgen lenslerde hidrofilik yüzey saglamak için islaticilar kullanilir. Production steps of the invention; 0.025% by weight polyvinyl prolidone in 100 mL water at 50°C (PVD) is added (10), the temperature is reduced to 25 0C and 15 min. mixing (20), disodium (NazEDTA) addition (70), 25 0C, at least 30 minutes. mixing (80), % by weight, at least at 25 0C Mixing for 1 hour (100), filtering under aseptic conditions (110) and 2 hours resting (120). ( Figure 1 and Figure 2) Detailed Description of the Invention: In hard and gas permeable lenses, wetting agents are used to provide a hydrophilic surface.
Bunlar lens takildiktan 5-10 dk. sonra dogal gözyasi akisi ile temizlenirler. Baslicalari: Polivinil alkol (lens yüzeyini uzun süre islak tutar, koruyucular ve kornea ile geçimlidir), duasorb (suda çözünen polimerik bir sistem, DUASORB (%01 dekstran 70, %03 hipromelloz), polioksamer 407 (noniyonik sürfaktan (yüzey aktif madde); emülgatör. Normalde karisim halinde bulunmayacak iki sivinin birbirinden ayrisinasini önler), PVP, metil selülozdur. Bunun disinda çok amaçli kontakt lens çözeltilerinde Ca2+ gibi iyonlarin ve tuzlarin koruyucu ile selat olusturmasini önlemek ve koruyucuya sinerjik etki için EDTA ve disodyum edetat eklenir. Protein zincirleri birbirine baglanirken ayni zamanda kalsiyum iyonlari ile köprü yaparak kontakt lense de baglanirlar. EDTA 'nin negatif elektrik yüklü gruplari kalsiyumun pozitif elektrik yüküne baglanarak olusan köprüyü kirarlar ve proteinleri lens üzerinden uzaklastirirlar. These are 5-10 minutes after the lens is attached. then they are cleaned with natural tears. The main ones are: Polyvinyl alcohol (keeps the lens surface wet for a long time, with preservatives and cornea compatible), duasorb (a water-soluble polymeric system, DUASORB (01% dextran) 70, 03% hypromellose), polyoxamer 407 (nonionic surfactant (surfactant); emulsifier. Separation of two liquids that would not normally be in a mixture prevents), PVP is methyl cellulose. Apart from this, multi-purpose contact lens solutions To prevent ions and salts such as Ca2+ from forming chelate with the preservative and to protect the preservative. EDTA and disodium edetate are added for synergistic effect. Protein chains interlocking While bonding, it also bridges the calcium ions to the contact lens. they connect. The negatively charged groups of EDTA are the positively charged groups of calcium. they break the bridge formed by binding to the charge and remove the proteins from the lens.
Ayrica, lensin takilirken korneaya yapismasim önlemek ve lakrimal siviya es osmolarite saglamak için NaCl ve KCl gibi tuzlar tonisite ayarlayici olarak kullanilir. Baslica borat, sitrat ve fosfat tamponlari durulama ve yikama/bekletme çözeltilerinde gözyasi pH' sinin saglanmasi için (pH: bütün mikroorganizmalari yok etme sirri, birlesimindeki çok etkili bir mikroorganizma öldürücü olan polihekzanid (polyhexamethylene biguanide), isimli polimer madde sayesindedir. Polihekzanid (polyhexamethylene biguanide) kendini tekrarlayan biguanide kimyasal gruplardan olusmaktadir. Polihekzanid 'in aktivitesinin yüksek olmasi nedeniyle mikroorganizmalari öldürmek için çok düsük konsantrasyon ile göz kornea hücrelerine zarar vermeksizin dezenfeksiyon etkinligi saglanmaktadir. In addition, it is necessary to prevent the lens from adhering to the cornea during insertion and to increase the co-osmolarity of the lacrimal fluid. Salts such as NaCl and KCl are used as tonicity adjusters. mainly borate, Tear pH' in citrate and phosphate buffers rinse and wash/hold solutions (pH: all The secret of destroying microorganisms is a very effective microorganism in its combination. polymer substance named polyhexanide (polyhexamethylene biguanide), which is lethal thanks. Polyhexanide (polyhexamethylene biguanide) repetitive It consists of biguanide chemical groups. High activity of polyhexanide with very low concentration to kill microorganisms due to Disinfection efficiency is provided without damaging the corneal cells.
Poliheksanid, Cilt ve mukoz membrandaki yüzey gerilimini azaltarak 'yatistirma' etkisi saglarken ayni zamanda hizli sekilde bakterisidal ve fungusidal etki gösteren bir maddedir. Polihekzanid özellikle, dokular ile biyolojik olarak uyumludur. Doku yüzeyleri üzerinde oldukça pozitif bir temizlik etkisi gösterir ve uygulanan tüm alanlarda sürekli bir nemlendirme saglar. Polyhexanide, 'soothing' by reducing surface tension in skin and mucous membranes It is a fast-acting bactericidal and fungicidal effect while providing the effect of is the substance. In particular, polyhexanide is biocompatible with tissues. Tissue It has a very positive cleaning effect on the surfaces and Provides continuous moistening in areas.
Kontak lens solüsyonunun ideal günlük temizleme etkinligi formülünde yer alan Poloksamer sayesinde gerçeklesmektedir. Günlük temizleme sirasindaki mekanik sürtünme ve durulama islemi poloksamerin etkisi ile daha da kuvvetli olmaktadir. Çok amaçli kontakt lens solüsyon içinde saklanirken, poloksamer etkisini sürdürerek lens üzerinde protein, lipid ve diger depozitlerin birikmesini önler. Amfifilik yapilari nedeniyle, polimerler, endüstriyel uygulamalarda yararli kilan yüzey aktif madde özelliklerine sahiptir. Baska seylerin yani sira, hidrofobik, yagli maddelerin suda çözünürlügünü arttirmak veya farkli hidrofobikliklere sahip iki maddenin karisabilirligini arttirmak için kullanilabilirler. Bu nedenle, bu polimerler endüstriyel uygulamalarda, kozmetik ürünlerde ve farmasötik preparatlarda yaygin olarak kullanilmaktadir. Ayrica poloksamer lens konforuna yardimci olan islatma ve yaglama özelliklerine de sahip bir kimyasal maddedir. Noniyonik yüzey aktif maddeler olarak kullanilan poloksaminler (Tetronic), bir merkezi etilendiamin parçasina bagli poli (etilen oksit) -poli (propilen oksit) (PEO-PPO) bloklarinin dört kolu tarafindan olusturulan X-sekilli amfifilik blok kopolimerleridir. Böyle bir yapi, sicaklik ve pH duyarliligi gibi çok tepki veren davranislar saglar. Nispeten düsük konsantrasyonlarda fakat kritik misel konsantrasyonun (CMC) üzerinde, poloksaminler polimerik miseller üretir. Hidrofobik bir çekirdegin mevcudiyetinden dolayi, bu nanokarterler suda iyi çözünmeyen ilaçlarin çözündürülmesi ve stabilize edilmesinde yararlidir. Included in the ideal daily cleaning efficiency formula of contact lens solution It happens thanks to poloxamer. Mechanical during daily cleaning The friction and rinsing process becomes even stronger with the effect of poloxamer. A lot While the purpose-built contact lens is stored in solution, the poloxamer maintains its effect. It prevents the accumulation of protein, lipid and other deposits on it. Amphitheater structures polymers are surfactants, which makes them useful in industrial applications. has features. Among other things, hydrophobic, oily substances in water to increase the solubility of two substances with different hydrophobicities. can be used to increase their miscibility. Therefore, these polymers are industrial widely used in applications, cosmetic products and pharmaceutical preparations is used. Wetting and lubricating, which also aids in poloxamer lens comfort. It is a chemical substance with properties. As nonionic surfactants The poloxamines (Tetronic) used are polyethylene bonded to a central ethylenediamine moiety. by the four branches of (ethylene oxide)-poly (propylene oxide) (PEO-PPO) blocks X-shaped amphiphilic block copolymers formed. Such a structure, temperature and pH It provides highly responsive behaviors such as sensitivity. At relatively low concentrations but above the critical micelle concentration (CMC), poloxamines are polymeric micelles. produces. Due to the presence of a hydrophobic core, these nanocartridges do well in water. It is useful in dissolving and stabilizing insoluble drugs.
Normal gözyasi film özellikleri (örnegin pH, osmolarite, viskozite, yüzey gerilimi) ile lens solüsyonlarinin özellikleri arasindaki farklar gözde rahatsizliklara neden olabilir. with normal tear film properties (eg pH, osmolarity, viscosity, surface tension) Differences in properties of lens solutions may cause eye discomfort.
Lens solüsyonlari temizlik, rahatlik ve dezenfekte maddeleri yönünden formüle edilir. Lens solutions are formulated for cleaning, comfort and disinfecting agents.
Ancak formülasyonlarin farkli olmasindan dolayi fiziksel özellikler, konfor derecesi ve dezenfekte etme derecesi de farkli olur. Lensleri temizlemek ve artiklardan uzak tutmak göz enfeksiyonu riskini azaltir. Gözyasi proteinlerini denatürasyona karsi korumak hastanin konforunu artirir ve antimikrobiyal aktiviteye katki saglar. However, due to the different formulations, physical properties, comfort level and The degree of disinfection also differs. Cleaning lenses and keeping them free of debris reduces the risk of eye infection. Protecting tear proteins against denaturation It increases the comfort of the patient and contributes to the antimicrobial activity.
Mevcut bulusta ürünün üretim basamaklari su sekildedir; 50°C, 100 mL suya agirlikça olarak (optimum vizkozite özellikle kontakt lensin göze takilma ve çikarilmasinda kolaylik saglamaktadir. Ayrica yüksek Vizkosite degerleri kontakt lensin göze ilk takilma aninda sadece bulanik görmeye yol açmakla kalmaz ayni zamanda yapisma hissi yaratir) ilave edilmesi ile baslar. Daha sonra sicaklik 25°C ”ye düsürülerek ortalama 15 dakika karistirilmasi ile proses devam ettirilmektedir. Daha sonra sirasiyla KLTS solüsyonun yüzey gerilimini ayarlamak/temizleme kapasitesini arttirmak için agirlikça % 0,205 poloksamer 407 ve protein giderici ve göz sivi pH ,ni saglamak için göze geri dönülmez zarar verirken standart degerlerde sapma, sizlama ve aci hissi yaratabilmektedir. Daha sonra solüsyona agirlikça % 0,171 sodyum 15 klorür (NaCl) (osmotik basinç göz konforunda son derece önemli rol oynar, özellikle göz kurulugu olan hastalarda yüksek osmolarite göz konforuna önemli derecede düsürür) ilave edilmektedir ve karisim 10 dakika kadar 1200 rpm hizinda karistirilmaktadir. Sonraki basamakta, solüsyona agirlikça % ilave edilmektedir. Karisimin 25 0C ,de en az 30 dakika karistirilmasimn ardindan agirlikça saat kadar karistirilmasinin ardindan aseptik kosullarda filtrelerden geçirilmekte ve 2 saat kadar dinlendirilmektedir. (Sekil 1 ve Sekil 2) 50°C, ilave edilmesi. sicakligin 25 °C 'ye düsürülerek 15 dk. karistirilmasi, agirlikça % 0,205 Poloxamer 407 eklenmesi, eklenmesi, agirlikça % 0,171 sodyum 15 klorür (NaCl) eklenmesi, dk. 1200 rpm hizinda karistirilmasi, agirlikça % eklenmesi, °C 'de en az 30 dk. karistirilmasi, agirlikça % eklenmesi, 111111111 °C 'de en az 1 saat karistirilmasi, aseptik kosullarda filtrelerden geçirilmesi ve 2 saat dinlendirilmesidir. In the present invention, the production steps of the product are as follows; 50°C by weight of 100 mL water (optimal viscosity especially for contact lens insertion and removal) provides convenience. In addition, high Viscosity values are the first time the contact lens gets into the eye. At the time of attachment, it not only causes blurred vision, but also adhesion. It starts with the addition of the . Then the temperature was reduced to 25°C. The process is continued with an average of 15 minutes of mixing. Then in order KLTS to adjust the surface tension of the solution/increase the cleaning capacity 0.205 wt% poloxamer 407 and protein remover and to maintain eye fluid pH Deviation in standard values, tingling and pain sensation while causing irreversible damage to the eye can create. Then, 0.171 wt% sodium 15 chloride (NaCl) was added to the solution. (osmotic pressure plays an extremely important role in eye comfort, especially eye dryness. High osmolarity significantly reduces eye comfort in patients with and the mixture is mixed at 1200 rpm for 10 minutes. Next Adding % by weight to the solution in step is being done. After mixing the mixture at 25 0C for at least 30 minutes, After mixing for about an hour, it is filtered under aseptic conditions and is rested for an hour. (Figure 1 and Figure 2) 50°C, additional to be made. 15 minutes by reducing the temperature to 25 ° C. mixing, adding 0.205 wt% Poloxamer 407, adding, adding 0.171 wt% sodium 15 chloride (NaCl), min. Mixing at 1200 rpm, adding % by weight, At least 30 min at °C. mixing, adding % by weight, 111111111 Stirring for at least 1 hour at °C, filtering under aseptic conditions and 2 hours rest.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2021/015778A TR2021015778A2 (en) | 2021-10-11 | 2021-10-11 | MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2021/015778A TR2021015778A2 (en) | 2021-10-11 | 2021-10-11 | MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD |
Publications (1)
Publication Number | Publication Date |
---|---|
TR2021015778A2 true TR2021015778A2 (en) | 2021-10-21 |
Family
ID=84046180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2021/015778A TR2021015778A2 (en) | 2021-10-11 | 2021-10-11 | MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR2021015778A2 (en) |
-
2021
- 2021-10-11 TR TR2021/015778A patent/TR2021015778A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101932301B (en) | Opthalmic compositions with an amphoteric surfactant and an anionic biopolymer | |
JP2820744B2 (en) | Uses of stabilized chlorine dioxide in ophthalmic formulations | |
US4409205A (en) | Ophthalmic solution | |
JP4969052B2 (en) | Ophthalmic composition | |
CN103269686B (en) | Contact lens ophthalmic composition | |
JP5938616B2 (en) | Contact lens solution | |
TW200930383A (en) | Methods and compositions for treating dry eye | |
JP2003160482A (en) | Ophthalmic solution and contact lens solution | |
AU2014209426B2 (en) | Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions | |
JP5941524B2 (en) | Ophthalmic composition for silicone hydrogel contact lens | |
CN1182877C (en) | Composition for treaitng contact lens and its application | |
US4421665A (en) | Contact lens cleaning composition containing lipid solvent and method of using | |
EP2365806A1 (en) | Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid | |
WO2008109397A2 (en) | Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions | |
KR20100092843A (en) | contact lens preservative | |
JP2005513112A (en) | Composition for treating contact lenses in the eye | |
KR101726029B1 (en) | Ophthalmic compositions with alkoxylated natural waxes | |
KR100354606B1 (en) | Composition of multi-purpose solution for treating contact lens | |
JP4065591B2 (en) | Contact lens solution and contact lens cleaning method using the same | |
TR2021015778A2 (en) | MULTIFUNCTIONAL ECONOMIC CONTACT LENS CLEANING SOLUTION AND PRODUCTION METHOD | |
JP2002193815A (en) | Eye drops for prevention of corneal drying for ophthalmic operation | |
JP2010215601A (en) | Eye drop for silicone hydrogel contact lens | |
JP2003057610A (en) | Liquid composition for contact lens | |
JP2012198428A (en) | Composition for contact lens | |
JP4533110B2 (en) | Ophthalmic solution |